Literature DB >> 30545877

Alzheimer's disease: The right drug, the right time.

Todd E Golde1, Steven T DeKosky1, Douglas Galasko2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30545877     DOI： 10.1126/science.aau0437

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  41 in total

1.  Capturing Aβ42 aggregation in the cell.

Authors:  Francesco Bemporad; Cristina Cecchi; Fabrizio Chiti
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

Review 2.  Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges?

Authors:  Stefan Prokop; Virginia M Y Lee; John Q Trojanowski
Journal:  Prog Mol Biol Transl Sci       Date:  2019-10-24       Impact factor: 3.622

Review 3.  The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.

Authors:  Elizabeth R Sharlow; Mehmet Murat Koseoglu; George S Bloom; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2019-05-16       Impact factor: 1.738

4.  Acoustofluidic multimodal diagnostic system for Alzheimer's disease.

Authors:  Nanjing Hao; Zeyu Wang; Pengzhan Liu; Ryan Becker; Shujie Yang; Kaichun Yang; Zhichao Pei; Peiran Zhang; Jianping Xia; Liang Shen; Lin Wang; Kathleen A Welsh-Bohmer; Laurie Sanders; Luke P Lee; Tony Jun Huang
Journal:  Biosens Bioelectron       Date:  2021-10-29       Impact factor: 10.618

5.  A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer's Disease by Dual Inhibition of Acetylcholinesterase and Inflammation.

Authors:  Chan Liu; Zhipei Sang; Hong Pan; Qin Wu; Yu Qiu; Jingshan Shi
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

6.  Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease.

Authors:  William J Jagust; Susan M Landau
Journal:  Neurology       Date:  2021-01-06       Impact factor: 9.910

7.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

8.  Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer's disease.

Authors:  Seung-Jun Yoo; Gowoon Son; Jisub Bae; So Yeun Kim; Yong Kyoung Yoo; Dongsung Park; Seung Yeop Baek; Keun-A Chang; Yoo-Hun Suh; Yeong-Bae Lee; Kyo Seon Hwang; YoungSoo Kim; Cheil Moon
Journal:  Sci Rep       Date:  2020-07-08       Impact factor: 4.379

9.  West Nile Virus-Induced Neurologic Sequelae-Relationship to Neurodegenerative Cascades and Dementias.

Authors:  Amy Y Vittor; Maureen Long; Paramita Chakrabarty; Lauren Aycock; Vidya Kollu; Steven T DeKosky
Journal:  Curr Trop Med Rep       Date:  2020-02-18

Review 10.  Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.

Authors:  Germán Plascencia-Villa; George Perry
Journal:  Antioxid Redox Signal       Date:  2020-07-17       Impact factor: 8.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.